Kewei Xu
No. 107 Yan Jiang West Road
Guangzhou, 510120, China
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 80 publications
Corrigendum to "PSMA RNA aptamer A10-3.2 conjugated with indocyanine green for rapid intraoperative imaging and effective mild photothermal therapy of prostate cancer" [Int. J. Biol. Macromol. 2026 Feb; 341(Pt 2):150303].
Journal: International journal of biological macromolecules
Published: July 29, 2026
A serum-clinical composite model for prostate cancer diagnosis: multicenter validation and CRISPR/Cas13a-based detection.
Journal: The journal of liquid biopsy
Published: June 22, 2026
Metabolic CRISPR screening identifies RPE as a key regulator of acquired enzalutamide resistance through FKBP5 destabilization in prostate cancer.
Journal: Oncogene
Published: May 02, 2026
Evaluating global clinical trials and development trends of antibody-drug conjugates.
Journal: Biomarker research
Published: April 28, 2026
Discovery and Engineering of a Rat Endogenous Retrovirus Reverse Transcriptase for Efficient Prime Editing.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 07, 2026
Premature menopause and risk of kidney stone disease: evidence from the UK biobank and National Health and Nutrition Examination Survey.
Journal: Menopause (New York, N.Y.)
Published: December 13, 2025
ANXA2-mediated Phagocytosis Generates AR+ Macrophages to Confer Enzalutamide Resistance in Prostate Cancer.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: December 02, 2025
Beyond valganciclovir: A meta-analysis of letermovir's safety and efficacy in cytomegalovirus prophylaxis after solid organ transplantation.
Journal: BMC infectious diseases
Published: November 09, 2025
Antibody-Drug Conjugates in Oncology: Principles, Clinical Development, and Future Directions.
Journal: MedComm
Published: October 20, 2025
A global multidimensional analysis of the chimeric antigen receptor T-cell therapy clinical trial landscape and development trends.
Journal: Biomarker research
Published: September 15, 2025
M2 macrophage related genes predict prognosis and drug response in prostate cancer.
Journal: Discover oncology
Published: September 15, 2025
PSMA RNA aptamer A10-3.2 conjugated with indocyanine green for rapid intraoperative imaging and effective mild photothermal therapy of prostate cancer.
Journal: International journal of biological macromolecules
Published: August 27, 2025
Last Updated: 09/26/2026